Christer Janson

Christer Janson

Uppsala Universitet

H-index: 115

Europe-Sweden

About Christer Janson

Christer Janson, With an exceptional h-index of 115 and a recent h-index of 59 (since 2020), a distinguished researcher at Uppsala Universitet, specializes in the field of asthma, COPD, allergy sleep.

His recent articles reflect a diverse array of research interests and contributions to the field:

Association between lung function and dyspnoea and its variation in the multinational Burden of Obstructive Lung Disease (BOLD) study

Biomarkers of chronic airflow limitation and COPD identified by mass spectrometry

Respiratory symptoms, exacerbations and sleep disturbances are more common among participants with asthma and chronic airflow limitation: an epidemiological study in Estonia …

Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical …

Does allergy decrease with age?

EXACOS CARBON: Describing the Greenhouse Gas Emissions of Healthcare Resource Utilization by Frequency and Severity of COPD Exacerbation in England

Enhancing EQ-5D-5L sensitivity in capturing the most common symptoms in post COVID-19 patients: an exploratory cross-sectional study with focus on fatigue, memory/concentration …

Sleep Apnea Indices Associated with Markers of Inflammation and Cardiovascular Disease: A Proteomic Study in the MUSTACHE Cohort

Christer Janson Information

University

Position

___

Citations(all)

45125

Citations(since 2020)

17094

Cited By

34899

hIndex(all)

115

hIndex(since 2020)

59

i10Index(all)

522

i10Index(since 2020)

425

Email

University Profile Page

Uppsala Universitet

Google Scholar

View Google Scholar Profile

Christer Janson Skills & Research Interests

asthma

COPD

allergy sleep

Top articles of Christer Janson

Title

Journal

Author(s)

Publication Date

Association between lung function and dyspnoea and its variation in the multinational Burden of Obstructive Lung Disease (BOLD) study

Pulmonology

A Müller

EF Wouters

P Koul

T Welte

I Harrabi

...

2024/4/13

Biomarkers of chronic airflow limitation and COPD identified by mass spectrometry

ERJ open research

Magnus Molin

Anne Incamps

Manon Lemasson

Mats Andersson

Eleftheria Pertsinidou

...

2024/1/1

Respiratory symptoms, exacerbations and sleep disturbances are more common among participants with asthma and chronic airflow limitation: an epidemiological study in Estonia …

BMJ open respiratory research

Stephanie Mindus

Thorarinn Gislason

Bryndis Benediktsdottir

Rain Jogi

Robert Moverare

...

2024/2/1

Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical …

Pulmonary Therapy

Annette Kainu

Ville A Vartiainen

Witold Mazur

Hanna Hisinger-Mölkänen

Federico Lavorini

...

2024/1/3

Does allergy decrease with age?

Revue Française d'Allergologie

C Janson

2024/4/1

EXACOS CARBON: Describing the Greenhouse Gas Emissions of Healthcare Resource Utilization by Frequency and Severity of COPD Exacerbation in England

J Bell

E Graul

C Nordon

C Kallis

HR Whittaker

...

2024/5

Enhancing EQ-5D-5L sensitivity in capturing the most common symptoms in post COVID-19 patients: an exploratory cross-sectional study with focus on fatigue, memory/concentration …

Helena Janols

Carl Wadsten

Christoffer Forssell

Elena Raffeti

Christer Janson

...

2024/4/9

Sleep Apnea Indices Associated with Markers of Inflammation and Cardiovascular Disease: A Proteomic Study in the MUSTACHE Cohort

Annals of the American Thoracic Society

Mirjam Ljunggren

Xingwu Zhou

Jenny Theorell-Haglöw

Christer Janson

Karl A Franklin

...

2024/1

Association between physical activity over a 10-year period and current insomnia symptoms, sleep duration and daytime sleepiness: a European population-based study

BMJ open

Erla Bjornsdottir

Elin Helga Thorarinsdottir

Eva Lindberg

Bryndis Benediktsdottir

Karl Franklin

...

2024/3/1

Global mortality and readmission rates following COPD exacerbation-related hospitalization: a meta-analysis of 65945 individual patients: a meta-analysis of 65 945 individual …

ERJ Open Research

Kiki Waeijen-Smit

Mieke Crutsen

Spencer Keene

Marc Miravitlles

Ernesto Crisafulli

...

2024/1/1

Spirometric patterns in young and middle-aged adults: a 20-year European study

thorax

Anne-Elie Carsin

Judith Garcia-Aymerich

Simone Accordini

Shyamali Dharmage

Bénédicte Leynaert

...

2024/2/1

Pharmacological treatment of asthma in Sweden from 2005 to 2015

Journal of Asthma

Caroline Ahlroth Pind

Björn Ställberg

Karin Lisspers

Josefin Sundh

Marta A Kisiel

...

2024/4/2

Development and Validation of an Individualised Risk Prediction Model for Exacerbations in Patients With Severe Asthma in Real-world Settings

W Chen

D Price

CP Yadav

RW Beasley

C Janson

...

2024/5

Nocturnal gastro-oesophageal reflux and respiratory symptoms are increased in sleep apnoea: comparison with the general population

BMJ Open Respiratory Research

Össur Ingi Emilsson

Thor Aspelund

Christer Janson

Bryndis Benediktsdottir

Sigurdur Juliusson

...

2024/3/1

Patient-reported Worsenings of Their Asthma and/or COPD (NOVELTY)

H Muellerova

E Rapsomaniki

R Hughes

J Marshall

L Belton

...

2024/5

CRP, fibrinogen, leukocytes, and blood cell indices as prognostic biomarkers of future COPD exacerbation frequency: the TIE cohort study

Jens Ellingsen

Christer Janson

Kristina Bröms

Maria Hårdstedt

Marieann Högman

...

2024

Disease burden and unmet need for acute allergic reactions–A patient perspective

World Allergy Organization Journal

Emelie Andersson

Sofia Löfvendahl

Sara Olofsson

Karin Wahlberg

Leif Bjermer

...

2024/4/1

Prevalence of chronic cough, its risk factors and population attributable risk in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study

EClinicalMedicine

Hazim Abozid

Jaymini Patel

Peter Burney

Sylvia Hartl

Robab Breyer-Kohansal

...

2024/2/1

A comparative study of multiple biomarkers levels in complicated versus noncomplicated type 2 diabetic patients

Cellular and Molecular Biology

Hemin Mohamad Hussein

Ahmed Alkhuzai

Christer Janson

Kawa Amin

2024/4/28

Does ICS treatment increase the risk of pneumonia in asthma?

Christer Janson

2024/2/22

See List of Professors in Christer Janson University(Uppsala Universitet)